These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Production and characterization of a monoclonal antibody against recombinant cathepsin L1 of Fasciola gigantica. Anuracpreeda P; Srirakam T; Pandonlan S; Changklungmoa N; Chotwiwatthanakun C; Tinikul Y; Poljaroen J; Meemon K; Sobhon P Acta Trop; 2014 Aug; 136():1-9. PubMed ID: 24736227 [TBL] [Abstract][Full Text] [Related]
24. Detection of circulating 54 kDa antigen in sera of bovine calves experimentally infected with F. gigantica. Velusamy R; Singh BP; Sharma RL; Chandra D Vet Parasitol; 2004 Jan; 119(2-3):187-95. PubMed ID: 14746978 [TBL] [Abstract][Full Text] [Related]
25. Detection of circulating antigen in sera of Fasciola gigantica-infected cattle with antibodies reactive with a Fasciola-specific 88-kDa antigen. Fagbemi BO; Obarisiagbon IO; Mbuh JV Vet Parasitol; 1995 Jun; 58(3):235-46. PubMed ID: 7571328 [TBL] [Abstract][Full Text] [Related]
27. Protection against Fasciola gigantica infection in mice by vaccination with recombinant juvenile-specific cathepsin L. Sansri V; Meemon K; Changklungmoa N; Kueakhai P; Chantree P; Chaichanasak P; Lorsuwannarat N; Itagaki T; Sobhon P Vaccine; 2015 Mar; 33(13):1596-601. PubMed ID: 25701317 [TBL] [Abstract][Full Text] [Related]
28. Potential of recombinant 2-Cys peroxiredoxin protein as a vaccine for Fasciola gigantica infection. Sangpairoj K; Apisawetakan S; Changklungmoa N; Kueakhai P; Chaichanasak P; Sobhon P; Chaithirayanon K Exp Parasitol; 2018 Nov; 194():16-23. PubMed ID: 30240576 [TBL] [Abstract][Full Text] [Related]
29. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica. Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548 [TBL] [Abstract][Full Text] [Related]
30. Immunodiagnosis of human fascioliasis using an antigen of Fasciola gigantica adult worm with the molecular mass of 27 kDa by a dot-ELISA. Intapan PM; Maleewong W; Nateeworanart S; Wongkham C; Pipitgool V; Sukolapong V; Sangmaneedet S Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):713-7. PubMed ID: 15115076 [TBL] [Abstract][Full Text] [Related]
31. Time-course analysis of antibody response by EITB and ELISA before and after chemotherapy in sheep infected with Fasciola gigantica. Guobadia EE; Fagbemi BO Vet Parasitol; 1995 Jun; 58(3):247-53. PubMed ID: 7571329 [TBL] [Abstract][Full Text] [Related]
32. The diagnostic efficacy of Fasciola gigantica coproantigen in naturally infected cattle and buffaloes. Hassan AA; El-Bahy MM; Abou-Zinadah NY; Shalaby HA J Egypt Soc Parasitol; 2008 Apr; 38(1):115-30. PubMed ID: 19143125 [TBL] [Abstract][Full Text] [Related]
33. Comparison of adult somatic and cysteine proteinase antigens of Fasciola gigantica in enzyme linked immunosorbent assay for serodiagnosis of human fasciolosis. Rokni MB; Massoud J; Hanilo A Acta Trop; 2003 Sep; 88(1):69-75. PubMed ID: 12943979 [TBL] [Abstract][Full Text] [Related]
34. Development of cathepsin-L cysteine proteinase based Dot-enzyme-linked immunosorbent assay for the diagnosis of Fasciola gigantica infection in buffaloes. Varghese A; Raina OK; Nagar G; Garg R; Banerjee PS; Maharana BR; Kollannur JD Vet Parasitol; 2012 Feb; 183(3-4):382-5. PubMed ID: 22055612 [TBL] [Abstract][Full Text] [Related]
35. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice. Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021 [TBL] [Abstract][Full Text] [Related]
36. Excretory-secretory antigenic components of adult Fasciola gigantica recognized by infected human sera. Intapan PM; Maleewong W; Wongkham C; Tomanakarn K; Ieamviteevanich K; Pipitgool V; Sukolapong V Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):579-83. PubMed ID: 10437961 [TBL] [Abstract][Full Text] [Related]
37. Comparison of humoral response in sheep to Fasciola hepatica and Fasciola gigantica experimental infection. Zhang W; Moreau E; Huang W; Chauvin A Parasite; 2004 Jun; 11(2):153-9. PubMed ID: 15224576 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the diagnostic potential of different immunological techniques using polyclonal antibodies against Fasciola gigantica excretory/secretory antigens in sheep. El Amir A; Rabee I; Kamal N; El Deeb S Egypt J Immunol; 2008; 15(1):65-74. PubMed ID: 20306670 [TBL] [Abstract][Full Text] [Related]
39. Immuno-diagnosis of bubaline fasciolosis with Fasciola gigantica cathepsin-L and recombinant cathepsin L 1-D proteases. Raina OK; Yadav SC; Sriveny D; Gupta SC Acta Trop; 2006 May; 98(2):145-51. PubMed ID: 16647680 [TBL] [Abstract][Full Text] [Related]
40. Fasciola gigantica enolase is a major component of worm tegumental fraction protective against sheep fasciolosis. Mahana N; Abd-Allah HA; Salah M; Tallima H; El Ridi R Acta Trop; 2016 Jun; 158():189-196. PubMed ID: 26970372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]